Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

12.080
-0.230-1.87%
Volume:36.70K
Turnover:437.49K
Market Cap:3.90B
PE:-7.59
High:12.410
Open:12.410
Low:11.540
Close:12.310
52wk High:206.000
52wk Low:11.540
Shares:323.00M
HK Float Shares:152.00M
Volume Ratio:0.17
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.591
ROE:-31.30%
ROA:-11.16%
PB:2.30
PE(LYR):-7.59
PS:195.66

Loading ...

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 19.88 Average Price

Reuters
·
Jul 15

BAO PHARMA-B repurchases 101,700 H-shares for HK$1.99 million; treasury stock rises to 834,900 shares

Bulletin Express
·
Jul 13

Shanghai Bao Pharmaceuticals Files HKEX Disclosure Return on Share Repurchase

Reuters
·
Jul 13

BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10

Stock News
·
Jul 10

Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity

Bulletin Express
·
Jul 09

Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share

Reuters
·
Jul 09

BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval

Deep News
·
Jul 09

BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback

Bulletin Express
·
Jul 08

BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8

Stock News
·
Jul 08

Bao Pharma appoints new joint company secretary and secures Listing Rules waiver

Bulletin Express
·
Jul 08

BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary

Stock News
·
Jul 08

Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent

Reuters
·
Jul 08

Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600

Bulletin Express
·
Jul 07

BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6

Stock News
·
Jul 06

Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares

Bulletin Express
·
Jul 06

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65

Reuters
·
Jul 06

Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection

Reuters
·
Jul 06

BAO PHARMA-B Surges Over 10% In Session Following Clinical Trial Approval for Recombinant Ulinastatin

Deep News
·
Jul 03

Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%

Bulletin Express
·
Jun 30

BAO PHARMA-B (02659) Repurchases 95,200 Shares for Approximately HK$1.686 Million on June 30

Stock News
·
Jun 30